Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $498.56 | 16 | 62.8% |
| Education | $295.82 | 4 | 37.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $268.94 | 4 | $0 (2018) |
| Janssen Biotech, Inc. | $249.14 | 5 | $0 (2021) |
| Pharmacyclics LLC, An AbbVie Company | $99.00 | 1 | $0 (2020) |
| Astellas Pharma US Inc | $77.09 | 4 | $0 (2019) |
| AbbVie, Inc. | $33.72 | 2 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $32.13 | 2 | $0 (2018) |
| PFIZER INC. | $22.44 | 1 | $0 (2021) |
| Gilead Sciences, Inc. | $11.92 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $56.17 | 3 | PFIZER INC. ($22.44) |
| 2020 | $141.43 | 3 | Pharmacyclics LLC, An AbbVie Company ($99.00) |
| 2019 | $103.65 | 2 | Janssen Biotech, Inc. ($84.95) |
| 2018 | $438.91 | 9 | Genentech USA, Inc. ($268.94) |
| 2017 | $54.22 | 3 | Novartis Pharmaceuticals Corporation ($20.55) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/28/2021 | PFIZER INC. | XALKORI (Drug), INLYTA, BAVENCIO | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: ONCOLOGY | ||||||
| 07/28/2021 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Oncology | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 08/26/2020 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Oncology | ||||||
| 05/07/2020 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: Oncology | ||||||
| 04/23/2020 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Oncology | ||||||
| 12/30/2019 | Astellas Pharma US Inc | PADCEV (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2019 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Education | In-kind items and services | $84.95 | General |
| Category: Oncology | ||||||
| 10/16/2018 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug), SANDOSTATIN LAR | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: ONCOLOGY | ||||||
| 10/04/2018 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Education | In-kind items and services | $99.95 | General |
| Category: Oncology | ||||||
| 09/18/2018 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 08/15/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: ONCOLOGY | ||||||
| 06/05/2018 | Genentech USA, Inc. | Perjeta (Biological) | Food and Beverage | In-kind items and services | $8.18 | General |
| Category: BioOncology | ||||||
| 05/16/2018 | AbbVie, Inc. | Venclexta (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Virology | ||||||
| 04/26/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: ONCOLOGY | ||||||
| 03/22/2018 | Genentech USA, Inc. | Perjeta (Biological) | Food and Beverage | In-kind items and services | $114.62 | General |
| Category: BioOncology | ||||||
| 03/20/2018 | Genentech USA, Inc. | Perjeta (Biological) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: BioOncology | ||||||
| 04/18/2017 | AbbVie, Inc. | Venclexta (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Virology | ||||||
| 04/04/2017 | Astellas Pharma US Inc | Tarceva (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Oncology | ||||||
| 03/09/2017 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 30 | 1,327 | 8,609 | $791,710 | $187,125 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1626 | Injection, granisetron hydrochloride, 100 mcg | Office | 2020 | 16 | 420 | $10,500 | $87.09 | 0.8% |
| J7030 | Infusion, normal saline solution , 1000 cc | Office | 2020 | 12 | 22 | $418.00 | $44.73 | 10.7% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2020 | 20 | 42 | $199.00 | $27.90 | 14.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2020 | 11 | 17 | $323.00 | $26.91 | 8.3% |
| J3490 | Unclassified drugs | Office | 2020 | 18 | 35 | $315.00 | $22.35 | 7.1% |
About Dr. Amy Irwin, M.D
Dr. Amy Irwin, M.D is a Hematology & Oncology healthcare provider based in Reston, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2008. The National Provider Identifier (NPI) number assigned to this provider is 1063685121.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Irwin, M.D has received a total of $794.38 in payments from pharmaceutical and medical device companies, with $56.17 received in 2021. These payments were reported across 20 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($498.56).
As a Medicare-enrolled provider, Irwin has provided services to 1,327 Medicare beneficiaries, totaling 8,609 services with total Medicare billing of $187,125. Data is available for 1 year (2020–2020), covering 30 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Reston, VA
- Active Since 04/10/2008
- Last Updated 12/23/2020
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1063685121
Products in Payments
- IMBRUVICA (Drug) $184.90
- Perjeta (Biological) $143.94
- Imbruvica (Drug) $99.00
- DARZALEX (Biological) $42.87
- XTANDI (Drug) $40.38
- Venclexta (Drug) $33.72
- XALKORI (Drug) $22.44
- ERLEADA (Drug) $21.37
- TASIGNA (Drug) $20.55
- PADCEV (Drug) $18.70
- Tarceva (Drug) $18.01
- AFINITOR (Drug) $11.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.